Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-14-000103
Filing Date
2014-11-10
Accepted
2014-11-10 13:00:06
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apri-201493010xq.htm 10-Q 812983
2 EXHIBIT apri-2014930xex311.htm EX-31.1 11625
3 EXHIBIT apri-2014930xex312.htm EX-31.2 11610
4 EXHIBIT apri-2014930xex321.htm EX-32.1 5252
5 EXHIBIT apri-2014930xex322.htm EX-32.2 5290
  Complete submission text file 0001017491-14-000103.txt   4265257

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apri-20140930.xml EX-101.INS 404848
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20140930.xsd EX-101.SCH 37159
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20140930_cal.xml EX-101.CAL 68398
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20140930_def.xml EX-101.DEF 184525
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20140930_lab.xml EX-101.LAB 450473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20140930_pre.xml EX-101.PRE 273449
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 141207702
SIC: 2834 Pharmaceutical Preparations